Table 2: Clinical characteristics.
|
|
Year
1 |
P
value |
Year
3 |
P
value |
||
|
No
Rejection N
= 40 |
Rejection N
= 6 |
|
No
Rejection N
= 28 |
Rejection N
= 3 |
|
|
|
Viral replication for
EBV, CMV or BKVa |
9
(22.5) |
1 (16.7) |
1.0 |
5 (17.8) |
1 (16.7) |
0.49 |
|
Urinary tract infections
N (%) |
11 (27.5) |
2
(33.3) |
1.0 |
2 (7.1) |
0 |
1.0 |
|
Donor specific
antibodies N (%) |
3 (7.5) |
5 (83.3) |
< 0.0002 |
4 (14.3) |
2 (66.7) |
0.09 |
|
eGFR
ml/min/1.73 m2b |
89 ± 31 |
54 ± 31 |
< 0.03 |
80 ± 26 |
53 ± 14 |
0.09 |
aViral PCR copies ≥ 1000/ml;
beGFR estimated glomerular filtration rate
by modified Schwartz: Ht (cm) × 0.413/serum
creatinine (mg/dl).
Abbreviations: EBV: Epstein Barr Virus; CMV: Cytomegalovirus; BKV: BK
Virus.